サマリー

抗菌治療薬の世界市場 2023-2027
Technavioは、抗菌治療薬市場を監視しており、2022年から2027年の間に514億米ドルで成長し、予測期間中のCAGRは5.63%で加速すると予測しています。当レポートでは、抗菌治療薬市場について、全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を行っています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、最近の医薬品承認と強力なパイプライン、製薬業界における政府機関の取り組み、微生物疾患に対する意識の高まりによって牽引されています。
Technavioの抗菌治療薬市場は以下のようにセグメント化されています：
用途別
- 抗ウイルス剤
- 抗菌
- 抗真菌剤
- 抗寄生虫剤
エンドユーザー別
- 薬局
- 病院・診療所
- 研究・学術機関
地域別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、治療用ワクチンの研究開発の増加が、今後数年間の抗菌剤治療薬市場の成長を促進する主要な理由の1つであるとしています。また、疾患診断モダリティの増加や併用療法に関する研究の活発化も、市場の大きな需要につながるでしょう。
Technavioは、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当レポートでは、抗菌治療薬市場について、以下の分野を取り上げています：
- 抗菌治療薬市場のサイジング
- 抗菌剤治療薬市場予測
- 抗菌剤治療薬市場の業界分析
Technavioの強固なベンダー分析は、クライアントの市場ポジションの向上に役立つように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Astellas Pharma Inc.を含む複数の主要抗菌治療薬市場ベンダーについて詳細に分析しています、Bavarian Nordic AS、Biocidium Biopharmaceuticals Inc.、Bristol Myers Squibb Co.、Cadila Pharmaceuticals Ltd.、CSL Ltd.、Emergent BioSolutions Inc. F. Hoffmann La Roche Ltd.、Gilead Sciences Inc. GlaxoSmithKline Plc、Inovio Pharmaceuticals Inc.、Johnson and Johnson Services Inc.、Merck and Co.Inc.、田辺三菱製薬株式会社、Novartis AG、Novavax Inc.、Pfizer Inc.、Sanofi SA、Wockhardt Ltd.などです。また、抗菌治療薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/antimicrobial-therapeutics-market-size-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global antimicrobial therapeutics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global antimicrobial therapeutics market 2017 - 2021 ($ billion)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Antiviral - Market size and forecast 2022-2027
o Exhibit 34: Chart on Antiviral - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Antiviral - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Antiviral - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Antiviral - Year-over-year growth 2022-2027 (%)
o 6.4 Antibacterial - Market size and forecast 2022-2027
o Exhibit 38: Chart on Antibacterial - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Antibacterial - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Antibacterial - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Antibacterial - Year-over-year growth 2022-2027 (%)
o 6.5 Antifungal - Market size and forecast 2022-2027
o Exhibit 42: Chart on Antifungal - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Antifungal - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Antifungal - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Antifungal - Year-over-year growth 2022-2027 (%)
o 6.6 Antiparasitic - Market size and forecast 2022-2027
o Exhibit 46: Chart on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Antiparasitic - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Antiparasitic - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Application
o Exhibit 50: Market opportunity by Application ($ billion)
o Exhibit 51: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Pharmacies - Market size and forecast 2022-2027
o Exhibit 56: Chart on Pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
o 7.4 Hospitals and clinics - Market size and forecast 2022-2027
o Exhibit 60: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
o 7.5 Research and academic institutes - Market size and forecast 2022-2027
o Exhibit 64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by End-user
o Exhibit 68: Market opportunity by End-user ($ billion)
o Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical
o Exhibit 111: Market opportunity By Geographical ($ billion)
o Exhibit 112: Data Tables on Market opportunity By Geographical ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 119: AbbVie Inc. - Overview
o Exhibit 120: AbbVie Inc. - Product / Service
o Exhibit 121: AbbVie Inc. - Key news
o Exhibit 122: AbbVie Inc. - Key offerings
o 12.4 Astellas Pharma Inc.
o Exhibit 123: Astellas Pharma Inc. - Overview
o Exhibit 124: Astellas Pharma Inc. - Product / Service
o Exhibit 125: Astellas Pharma Inc. - Key news
o Exhibit 126: Astellas Pharma Inc. - Key offerings
o 12.5 Bavarian Nordic AS
o Exhibit 127: Bavarian Nordic AS - Overview
o Exhibit 128: Bavarian Nordic AS - Product / Service
o Exhibit 129: Bavarian Nordic AS - Key offerings
o 12.6 Biocidium Biopharmaceuticals Inc.
o Exhibit 130: Biocidium Biopharmaceuticals Inc. - Overview
o Exhibit 131: Biocidium Biopharmaceuticals Inc. - Product / Service
o Exhibit 132: Biocidium Biopharmaceuticals Inc. - Key offerings
o 12.7 Bristol Myers Squibb Co.
o Exhibit 133: Bristol Myers Squibb Co. - Overview
o Exhibit 134: Bristol Myers Squibb Co. - Product / Service
o Exhibit 135: Bristol Myers Squibb Co. - Key news
o Exhibit 136: Bristol Myers Squibb Co. - Key offerings
o 12.8 Cadila Pharmaceuticals Ltd.
o Exhibit 137: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 138: Cadila Pharmaceuticals Ltd. - Product / Service
o Exhibit 139: Cadila Pharmaceuticals Ltd. - Key offerings
o 12.9 CSL Ltd.
o Exhibit 140: CSL Ltd. - Overview
o Exhibit 141: CSL Ltd. - Business segments
o Exhibit 142: CSL Ltd. - Key news
o Exhibit 143: CSL Ltd. - Key offerings
o Exhibit 144: CSL Ltd. - Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 Gilead Sciences Inc.
o Exhibit 150: Gilead Sciences Inc. - Overview
o Exhibit 151: Gilead Sciences Inc. - Product / Service
o Exhibit 152: Gilead Sciences Inc. - Key news
o Exhibit 153: Gilead Sciences Inc. - Key offerings
o 12.12 GlaxoSmithKline Plc
o Exhibit 154: GlaxoSmithKline Plc - Overview
o Exhibit 155: GlaxoSmithKline Plc - Business segments
o Exhibit 156: GlaxoSmithKline Plc - Key news
o Exhibit 157: GlaxoSmithKline Plc - Key offerings
o Exhibit 158: GlaxoSmithKline Plc - Segment focus
o 12.13 Johnson and Johnson Services Inc.
o Exhibit 159: Johnson and Johnson Services Inc. - Overview
o Exhibit 160: Johnson and Johnson Services Inc. - Business segments
o Exhibit 161: Johnson and Johnson Services Inc. - Key news
o Exhibit 162: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 163: Johnson and Johnson Services Inc. - Segment focus
o 12.14 Merck and Co. Inc.
o Exhibit 164: Merck and Co. Inc. - Overview
o Exhibit 165: Merck and Co. Inc. - Business segments
o Exhibit 166: Merck and Co. Inc. - Key news
o Exhibit 167: Merck and Co. Inc. - Key offerings
o Exhibit 168: Merck and Co. Inc. - Segment focus
o 12.15 Novartis AG
o Exhibit 169: Novartis AG - Overview
o Exhibit 170: Novartis AG - Business segments
o Exhibit 171: Novartis AG - Key offerings
o Exhibit 172: Novartis AG - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 173: Pfizer Inc. - Overview
o Exhibit 174: Pfizer Inc. - Product / Service
o Exhibit 175: Pfizer Inc. - Key news
o Exhibit 176: Pfizer Inc. - Key offerings
o 12.17 Sanofi SA
o Exhibit 177: Sanofi SA - Overview
o Exhibit 178: Sanofi SA - Business segments
o Exhibit 179: Sanofi SA - Key news
o Exhibit 180: Sanofi SA - Key offerings
o Exhibit 181: Sanofi SA - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 182: Inclusions checklist
o Exhibit 183: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 184: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 185: Research methodology
o Exhibit 186: Validation techniques employed for market sizing
o Exhibit 187: Information sources
o 13.5 List of abbreviations
o Exhibit 188: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global antimicrobial therapeutics market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Antiviral - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Antiviral - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Antiviral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Antiviral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Antibacterial - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Antibacterial - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Antibacterial - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Antibacterial - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Antifungal - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Antifungal - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Antifungal - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Antifungal - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Antiparasitic - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Antiparasitic - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Antiparasitic - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Application ($ billion)
Exhibits51: Data Table on Market opportunity by Application ($ billion)
Exhibits52: Chart on End-user - Market share 2022-2027 (%)
Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Pharmacies - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Pharmacies - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Research and academic institutes - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Research and academic institutes - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by End-user ($ billion)
Exhibits69: Data Table on Market opportunity by End-user ($ billion)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical ($ billion)
Exhibits112: Data Tables on Market opportunity By Geographical ($ billion)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: AbbVie Inc. - Overview
Exhibits120: AbbVie Inc. - Product / Service
Exhibits121: AbbVie Inc. - Key news
Exhibits122: AbbVie Inc. - Key offerings
Exhibits123: Astellas Pharma Inc. - Overview
Exhibits124: Astellas Pharma Inc. - Product / Service
Exhibits125: Astellas Pharma Inc. - Key news
Exhibits126: Astellas Pharma Inc. - Key offerings
Exhibits127: Bavarian Nordic AS - Overview
Exhibits128: Bavarian Nordic AS - Product / Service
Exhibits129: Bavarian Nordic AS - Key offerings
Exhibits130: Biocidium Biopharmaceuticals Inc. - Overview
Exhibits131: Biocidium Biopharmaceuticals Inc. - Product / Service
Exhibits132: Biocidium Biopharmaceuticals Inc. - Key offerings
Exhibits133: Bristol Myers Squibb Co. - Overview
Exhibits134: Bristol Myers Squibb Co. - Product / Service
Exhibits135: Bristol Myers Squibb Co. - Key news
Exhibits136: Bristol Myers Squibb Co. - Key offerings
Exhibits137: Cadila Pharmaceuticals Ltd. - Overview
Exhibits138: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits139: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits140: CSL Ltd. - Overview
Exhibits141: CSL Ltd. - Business segments
Exhibits142: CSL Ltd. - Key news
Exhibits143: CSL Ltd. - Key offerings
Exhibits144: CSL Ltd. - Segment focus
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: Gilead Sciences Inc. - Overview
Exhibits151: Gilead Sciences Inc. - Product / Service
Exhibits152: Gilead Sciences Inc. - Key news
Exhibits153: Gilead Sciences Inc. - Key offerings
Exhibits154: GlaxoSmithKline Plc - Overview
Exhibits155: GlaxoSmithKline Plc - Business segments
Exhibits156: GlaxoSmithKline Plc - Key news
Exhibits157: GlaxoSmithKline Plc - Key offerings
Exhibits158: GlaxoSmithKline Plc - Segment focus
Exhibits159: Johnson and Johnson Services Inc. - Overview
Exhibits160: Johnson and Johnson Services Inc. - Business segments
Exhibits161: Johnson and Johnson Services Inc. - Key news
Exhibits162: Johnson and Johnson Services Inc. - Key offerings
Exhibits163: Johnson and Johnson Services Inc. - Segment focus
Exhibits164: Merck and Co. Inc. - Overview
Exhibits165: Merck and Co. Inc. - Business segments
Exhibits166: Merck and Co. Inc. - Key news
Exhibits167: Merck and Co. Inc. - Key offerings
Exhibits168: Merck and Co. Inc. - Segment focus
Exhibits169: Novartis AG - Overview
Exhibits170: Novartis AG - Business segments
Exhibits171: Novartis AG - Key offerings
Exhibits172: Novartis AG - Segment focus
Exhibits173: Pfizer Inc. - Overview
Exhibits174: Pfizer Inc. - Product / Service
Exhibits175: Pfizer Inc. - Key news
Exhibits176: Pfizer Inc. - Key offerings
Exhibits177: Sanofi SA - Overview
Exhibits178: Sanofi SA - Business segments
Exhibits179: Sanofi SA - Key news
Exhibits180: Sanofi SA - Key offerings
Exhibits181: Sanofi SA - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations